Andra Ap Fonden Legend Biotech Corp Transaction History

Andra Ap Fonden

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 15, 2024	BUY	$57.25 - $69.74 $675,550 - $822,931	11,800 Added 22.78%	63,600 $3.83 Million
Q3 2023 Nov 09, 2023	BUY	$63.16 - $76.5 $884,240 - $1.07 Million	14,000 Added 37.04%	51,800 $3.48 Million
Q2 2023 Aug 09, 2023	SELL	$46.28 - $75.01 $1.04 Million - $1.68 Million	-22,400 Reduced 37.21%	37,800 $2.61 Million
Q1 2023 May 12, 2023	SELL	$43.42 - $57.37 $464,594 - $613,859	-10,700 Reduced 15.09%	60,200 $2.9 Million
Q4 2022 Feb 13, 2023	BUY	$38.8 - $55.46 $869,119 - $1.24 Million	22,400 Added 46.19%	70,900 $3.54 Million
Q3 2022 Nov 14, 2022	BUY	$38.15 - $57.1 $503,580 - $753,720	13,200 Added 37.39%	48,500 $1.98 Million
Q2 2022 Aug 15, 2022	SELL	$33.54 - $55.0 $144,222 - $236,500	-4,300 Reduced 10.86%	35,300 $1.94 Million
Q4 2021 Feb 15, 2022	BUY	$41.14 - $56.98 $1.63 Million - $2.26 Million	39,600 New	39,600 $1.85 Million

205

74.5M

371K

387K

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $6.7B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

Get notified when there are updates to the investment portfolio of Andra Ap Fonden, based on Form 13F filings with the SEC.

Stay updated on Andra Ap Fonden with notifications on news.